title: Renal replacement therapy as a treatment for severe refractory hypercalcemia.
authors: Department of Endocrinology, St Bartholomew's Hospital, London, UK - james.pittaway@bartshealth.nhs.uk.
authors: J F
authors: JF
authors: Pittaway
authors: U
authors: U
authors: Srirangalingam
authors: P L
authors: PL
authors: Hanson
authors: P
authors: P
authors: Jones
authors: W M
authors: WM
authors: Drake
mesh_terms: D000236:Adenoma / Q000150:complications / Q000601:surgery; D000328:Adult; D002277:Carcinoma / Q000150:complications / Q000601:surgery; D000069449:Cinacalcet; D004164:Diphosphonates / Q000627:therapeutic use; D004351:Drug Resistance; D004630:Emergencies; D005260:Female; D005665:Furosemide / Q000627:therapeutic use; D017583:Hemodiafiltration; D006440:Hemofiltration; D006801:Humans; D006887:Hydroxycholecalciferols / Q000627:therapeutic use; D006934:Hypercalcemia / Q000188:drug therapy / Q000209:etiology / Q000628:therapy*; D007011:Hypoparathyroidism / Q000209:etiology; D015459:Leukemia-Lymphoma, Adult T-Cell / Q000097:blood / Q000150:complications; D008297:Male; D008875:Middle Aged; D009281:Naphthalenes / Q000627:therapeutic use; D000077268:Pamidronate; D019283:Pancreatitis, Acute Necrotizing / Q000150:complications; D010282:Parathyroid Neoplasms / Q000150:complications / Q000601:surgery; D016105:Parathyroidectomy / Q000009:adverse effects
chemical_list: D004164:Diphosphonates; D006887:Hydroxycholecalciferols; D009281:Naphthalenes; D005665:Furosemide; D000077268:Pamidronate; D000069449:Cinacalcet; C008088:alfacalcidol